Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMangoceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Mangoceuticals Inc Earnings Date And Information
Mangoceuticals Inc last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 84.25 K for the quarter and had revenue of 615.87 K for the year. Mangoceuticals Inc has generated $-4 earnings per share over the last year ($-4.3993 diluted earnings per share) and currently has a price-to-earnings ratio of -0.21. Mangoceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Mangoceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q3 2025 | N/A | -$0.69 | N/A | N/A | $84.25 K |
| 08/14/2025 | Q2 2025 | N/A | -$0.54 | N/A | N/A | $168.11 K |
| 05/15/2025 | Q1 2025 | N/A | -$1.05 | N/A | N/A | $109.31 K |
| 03/20/2025 | Q4 2024 | N/A | -$0.60 | N/A | N/A | $105.25 K |
| 11/14/2024 | Q3 2024 | N/A | -$0.99 | N/A | N/A | $133.37 K |
| 08/14/2024 | Q2 2024 | N/A | -$1.37 | N/A | N/A | $163.16 K |
| 05/15/2024 | Q1 2024 | N/A | -$1.56 | N/A | N/A | $214.10 K |
| 04/01/2024 | Q4 2023 | N/A | -$1.98 | N/A | N/A | $244.37 K |
| 10/27/2023 | Q3 2023 | N/A | -$1.70 | N/A | $176.55 K | $245.16 K |
| 07/28/2023 | Q2 2023 | N/A | -$2.05 | N/A | $141.24 K | $141.24 K |
| 05/09/2023 | Q1 2023 | N/A | -$3.41 | N/A | N/A | $100.72 K |
| 12/31/2022 | Q4 2022 | N/A | -$0.75 | N/A | N/A | $8.94 K |
| 09/30/2022 | Q3 2022 | N/A | -$1.00 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.33 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.02 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.02 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mangoceuticals Inc Earnings: FAQ's
The conference call for Mangoceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Mangoceuticals Inc's latest earnings report can be read online.
Mangoceuticals Inc (:MGRX) has a recorded annual revenue of $615.87 K.
Mangoceuticals Inc (:MGRX) has a recorded net income of $-8,706,000.Mangoceuticals Inc has generated $-4.3993 earnings per share over the last four quarters.
Mangoceuticals Inc (:MGRX) has a price-to-earnings ratio of -0.21 and price/earnings-to-growth ratio is -0.02.